YM-1 (2, Figure 2) and JG-98 (3, Figure 2) were both shown to inhibit Hsp70–Bag3 interactions by a pulldown assay, and their treatments are sufficient to suppress tumor growth in mice that mirrors the effects of Hsp70 depletion [23,24]. Here, HSPA4 is linked to neoplasm.